CLINICAL_TRIALS
trial_result
· 2024-04-03
Clinical Trial Update: Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma [Phase 3]
Summary
Phase 3 randomized trial of ICT-107 in glioblastoma is suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Precision Life Sciences Group | Conditions: Glioblastoma Multiforme | Phase 3 | Status: SUSPENDED